Interactions industry

ADDN has interactions and collaborations with many industrial partners.
A few examples of IWT- or FP7-funded projects with industrial partners are indicated below:

GSK-DDW

OpenMedChem: Medicinal Chemistry Open Innovation Doctorates -Tuberculosis

Funding: Initial Training Network (MCA, FP7)
From: 01/10/2012 to 30/09/2016

Participant: Lab. of Medicinal Chemistry (UAMC)

J&J

Project:
Benzodiazepine analogues for antifungal research
- Participants: Lab. of Microbiology, Parasitology and Hygiene (LMPH), Lab. of Medicinal Chemistry (UAMC)
Project:
Immuno-PET: Immuno-positron emission tomography (PET) imaging as a potential biomarker for diagnosis and treatment in Alzheimer's disease.

This is a collaborative project with MICA & Laboratory for Translational Neuroscience.
- Funding: IWT O&O (IWT Activity Report 2012)
- Participant: Laboratory of Medicinal Chemistry (UAMC)

Dafra Pharma

Project:
Extensive pharmacological study of the new anti-leishmania candidate drug oleylphosphocholine (OIPC) and exploration of other therapeutic applications to maximize the valorization value.

Funding:

IWT SME (IWT Activity Report 2011)

Participant: Lab. of Microbiology, Parasitology and Hygiene (LMPH)